Compare VNET Group Inc (VNET) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
VNET Group Inc vs State Street SPDR S&P Biotech ETF — how do they compare? VNET Group Inc trades at $7.7 (market cap $2.19B), while State Street SPDR S&P Biotech ETF trades at $154.46. The key difference: State Street SPDR S&P Biotech ETF is trading nearer its 52-week high, VNET Group Inc nearer its low. Which is the better fit depends on your goals.
| VNET | XBI | |
|---|---|---|
Market Cap | $2.19B | — |
Sector | Technology | Broad Market / Factor |
52-Week High | $14.03 | $164.28 |
52-Week Low | $7.34 | $85.16 |
Enterprise Value | $5.32B | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About VNET Group Inc
VNET Group, formerly 21Vianet, is a leading carrier-neutral data center services provider in China. It operates a dual-core strategy: a large-scale retail business serving over 7,000 enterprise customers and an aggressive wholesale segment (Hyperscale 2.0) designed to meet the high-density power and cooling demands of large-scale AI and cloud platforms.
Read more on VNET →About State Street SPDR S&P Biotech ETF
XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →
